Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 36.70
-0.10 (-0.27%)
Mar 2, 2026, 4:58 PM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 2.84 billion as of March 2, 2026. Its market cap has decreased by -22.96% in one year.
Market Cap
2.84B
Enterprise Value
2.30B
Revenue
2.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.70
Market Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 2.84B, a decrease of -30.77%. That is a compound annual growth rate of -19.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.85B | -1.74% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.44B |
| Vicore Pharma Holding AB | 2.83B |
| Saniona AB | 2.57B |
| Diamyd Medical AB | 2.04B |
| Egetis Therapeutics AB | 1.81B |
| BioInvent International AB | 1.53B |
| Cantargia AB | 1.18B |
| Genovis AB (publ.) | 1.14B |